ArticleBMC cancer2018

Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia.

Luca Bertamini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.